Cryo-Cell International, Inc.CCELNYSE
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank14
3Y CAGR-10.5%
5Y CAGR-9.5%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-10.5%/yr
vs -7.4%/yr prior
5Y CAGR
-9.5%/yr
Consistent
Acceleration
-3.1pp
Decelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20251.11-57.2%
20242.59+47.3%
20231.76+13.7%
20221.55-53.1%
20213.30+80.5%
20201.83-11.8%
20192.07-1.6%
20182.11-7.7%
20172.28+29.4%
20161.76-